Meet the guy biohacking puppies to make them glow in the dark
By Kristen V. Brown,
Fusion
| 09. 28. 2016
It was after a home invasion almost a decade ago that David Ishee first got interested in breeding dogs. A burglar with a gun had broken into his home in Jackson, Mississippi, where Ishee was asleep along with his wife, 3-year-old-daughter and newborn son. Ishee pulled out his own shotgun and scared the would-be thief off. But he was unsettled wondering what might have happened had he not been around.
Ishee wanted a guard dog, and giant, docile mastiffs are good ones to have around little kids. Like so many carefully bred dogs, though, mastiffs are riddled with genetic disorders. So Ishee decided to start breeding them himself, with plans to increase their genetic diversity and hopefully make them healthier, happier and more fit. Over just a few generations, he saw results. Gone was the sagging skin and oversized head that makes so many mastiffs look goofy. He told me his dogs could jump higher and run faster than most other Mastiffs can.
But because the majority of the genetic disorders dogs suffer from are recessive, Ishee...
Related Articles
By Matthew Herper, Stat | 07.01.2026
Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece of science that generates as many questions as answers. They...
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Emily Baumgaetner Nunn, The New York Times | 07.20.2026
The National Institutes of Health recently announced a remarkable achievement: the world’s largest database of human genomes, a repository of information that the agency says will help usher in a new era in personalized medicine.
Scientists are already developing clinical...
By Risa Cromer, The Conversation | 07.17.2026